N23103
yw43h02.s1 Weizmann Olfactory Epithelium Homo sapiens cDNA clone IMAGE:255027 3', mRNA sequence.
357
mRNA
Homo sapiens
PD711017
JP 2021530475-A/23099: De novo Design of Protein Switches.
60
PRT
synthetic construct
HZ527884
JP 2016501039-A/23103: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PA527587
JP 2022502046-A/10369: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DL904847
JP 2014205669-A/23103: Method of constructing and screening libraries of peptide structures.
27
PRT
synthetic construct
MD269236
JP 2020517247-A/23103: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
PA338751
JP 2021522188-A/23103: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
DD549706
JP 2004508801-A/23103: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
OG507289
JP 2018534252-A/23103: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
33
PRT
synthetic construct
DJ152483
JP 2007228956-A/23101: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
LV568925
JP 2017029159-A/23103: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
HW858327
JP 2015051004-A/23055: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
FU797584
JP 2009528046-A/23101: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
PA393826
JP 2021533803-A/22909: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
MD755345
JP 2019507579-A/23103: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
DJ526903
JP 2010517930-A/23103: Method of constructing and screening libraries of peptide structures.
27
PRT
synthetic construct
MC551603
JP 2019525738-A/23103: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
10
PRT
synthetic construct
OG752622
JP 2021120380-A/23103: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
LF830259
JP 2016528161-A/23092: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
LF682324
JP 2016521556-A/23103: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
HW188131
JP 2013102767-A/23055: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DM797561
JP 2014068652-A/23103: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
MC164947
JP 2019500349-A/23103: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
LX120719
JP 2017506877-A/23101: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
HV879644
JP 2010507387-A/23055: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
DL613705
JP 2011092200-A/23103: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
DL032117
JP 2005512499-A/23103: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
770
DNA
synthetic construct
DM759797
JP 2014079248-A/23103: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
MC775213
JP 2018525446-A/23103: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
26
PRT
synthetic construct
OG659489
JP 2021500321-A/23103: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct